basic physical and chemical properties: white to grey-white, perhaps with a hint of yellow-orange color, sometimes slightly mottled, round, dopamin tablets with a beveled edge;
composition: 1 tablet (250 mg) contains Cinnabaris D3 25 mg, Echinacea D1 25 mg, Hydrastis D3 25 mg, Kalium bichromicum D3 25 mg;
excipients: lactose monohydrate, magnesium stearate, wheat starch.
Form of issue. Pills.
Pharmacotherapeutic group. A homeopathic medicinal product.
The pharmacological properties. Cinnabsin is a homeopathic combination drug. Cinnabaris quickly and securely free from such characteristic symptoms of inflammation around the sinuses, such as headaches, watery eyes, and from neuralgia in the face. Hydrastis and Kalium bichromicum are mainly with the acute and chronic course of the disease, which often occurs with prolonged sinusitis. All three ingredients help to relieve swelling of the mucous membranes and nose breathing. Echinacea helps support the immune system.
Indications for use. Acute and chronic inflammation of the sinuses (sinusitis).
Method of application and doses. Cinnabsin using the following way:
children aged 2 to 12 years: in acute conditions - 1 tablet every two hours (but not more than 8 tablets per day) until improvement occurs; after this, or for chronic conditions - 1 tablet 3 times a day;
adults and children over 12 years: in acute conditions - 1 tablet every hour (not to exceed 12 tablets per day) until improvement occurs; after this, or for chronic conditions: 1-2 tablets 3 times a day.
In chronic sinusitis it is recommended that more long-term treatment (4 to
Cinnabsin not recommended to take more than 8 weeks.
Tablets are taken half an hour before meals or half an hour after a meal, letting them slowly dissolve in your mouth. Children under 3 years recommended for ease of use dissolve tablets in small amount of water (for example in a teaspoon).
Side effects. In some cases, can be observed hypersensitivity reactions like skin rashes or gastro-intestinal disorders. Patients who used other drugs containing Echinacea was also noted allergic reactions. In the development of such undesirable phenomena should stop taking the drug.
When increased salivation after administration of the drug Cinnabsin it is recommended to reduce the dose or stop taking the drug.
Contraindications. The drug should not be administered in known hypersensitivity to chromium, Echinacea, and other species of the Compositae family or to any of the ingredients. Cinnabsin should not be used in progressive systemic diseases such as tuberculosis, leukaemia, leukemia, collagen diseases, auto immune diseases, multiple sclerosis, AIDS, HIV infection, chronic viral hepatitis.
Overdose. Overdose symptoms are still not known.
Features of the application. In the application of herbal medicines may be a temporary primary worsening of symptoms. In this case, you should reduce the frequency and dosage of the drug and, after the regression of undesirable symptoms to restore the drug according to instructions. In the case of expressed primary worsening, accompanied by poor tolerance of the drug, discontinue its use.
Caution for patients with lactose intolerance or celiac disease: Cinnabsin contains lactose and wheat starch.
Influence on velocity reactions in driving transport or operating other mechanisms are not.
Use the drug during pregnancy and lactation is possible only after an objective assessment of the ratio between the expected beneficial effects and potential risk.
Due to the lack of clinical data it is not recommended to use the drug in children under 2 years.
Interaction with other medicinal products. It is still not known.
The conditions and duration of storage. Store at room temperature (15-25 ° C) out of reach of children.
Shelf life - 5 years.